TY - JOUR T1 - Phytochemical regulation of RNA in treating inflammatory bowel disease and colon cancer: inspirations from Cell and Animal studies JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther DO - 10.1124/jpet.120.000354 SP - JPET-COM-2020-000354 AU - Guolin Zhang AU - Chi Zhang AU - Jia'ao Sun AU - Yongjian Xiong AU - Liang Wang AU - Dapeng Chen Y1 - 2021/01/01 UR - http://jpet.aspetjournals.org/content/early/2021/01/04/jpet.120.000354.abstract N2 - Recent studies suggest an important role for RNA, especially non-coding RNA, in inflammatory bowel disease (IBD) and colon cancer. Drug development based on regulating RNA rather than protein is a promising new area. Phytochemicals are naturally occurring plant-derived compounds with chemical diversity, biological activity, easy availability, and low toxicity. Many phytochemicals have been shown to exert protective effects on IBD and colon cancer through modulation of RNAs. The aim of this study was to summarize the advancements of phytochemicals in regulating RNA for the treatment of IBD and colon cancer. This review involves many phytochemicals including polyphenols, flavones, and alkaloids, which can influence various types of RNAs including microRNA (miRNA), long non-coding RNA (lncRNA), as well as messenger RNA (mRNA) by influencing a variety of upstream molecules or regulating epigenetic processes. The limitation for many current studies is that the specific mechanisms of phytochemicals regulating RNA have not been fully uncovered. Accompanied by more identified functions of RNAs, especially non-coding RNA functions, the screening of RNA-regulating phytochemicals has presented challenges as well as opportunities for the prevention and treatment of IBD and colon cancer. Significance Statement Non-coding RNAs, which constitute the majority of the human transcriptional genome, play a key role in the disease state and are considered as important therapeutic targets in inflammatory bowel disease (IBD) and colon cancer. Recent studies have shown that phytochemicals regulate the expression of many noncoding RNAs involved in IBD and colon cancer. Therefore, identifying the specific molecular mechanism of phytochemicals regulating non-coding RNA in disease models may result in novel and effective therapeutic opportunities. ER -